GOLDEN-5 In GOLDEN-5, improvements in Total scores were observed for glycopyrrolate/eFlow CS and tiotropium (Figure 3b)
The preclinical signal for BPC-157 is unusually consistent across independent research groups and across a wide range of injury models, pointing toward a compound with genuine biological activity rather than a laboratory artifact
Always test your ferritin , hemoglobin , and iron saturation before supplementing, and aim for ferritin levels in the optimal range (often 50100 ng/mL )
Studies show that without ongoing medication: Most patients regain 75-90% of lost weight within two years Many report unusually strong hunger signals after discontinuation Metabolic adaptation makes weight maintenance significantly more challenging Of all the potential long-term effects, bone health deserves special attention because: Bone loss occurs silently : Unlike digestive side effects that are immediately noticeable, bone loss happens gradually with no symptoms until a fracture occurs The effects can be permanent : Once significant bone loss occurs, it can be difficult to fully restore The consequences are serious : Osteoporotic fractures can lead to chronic pain, disability, and in the case of hip fractures, a 20-30% mortality rate in the first year Combination risk factors : Many people taking GLP-1 medications already have other risk factors for osteoporosis, creating a perfect storm for bone health problems Also read: Does Ozempic Cause Osteoporosis
There are currently no consensus treatment guidelines for MIS-A, however a recent review article with a sample size of 79 MIS-A patients, reported on the use of steroids (60.2%), intravenous immunoglobulin (37.2%), and biologics (10.2%) with an overall mortality rate of 5.1% [10]
